Skip to main content

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 5, Number 6, September 2005

Review article

Tumor Necrosis Factor: How to Make a Killer Molecule Tumor-Specific?
pp. 381-392(12)
Authors: Lucas, Rudolf; Kresse, Matthias; Latta, Markus; Wendel, Albrecht


Purine Nucleoside Analogues for the Treatment of Hematological Malignancies: Pharmacology and Clinical Applications
pp. 421-444(24)
Authors: Robak, T.; Korycka, A.; Kasznicki, M.; Wrzesien-Kus, A.; Smolewski, P.


Strategies for Targeting the Multidrug Resistance-1 (MDR1)/P-gp Transporter in Human Malignancies
pp. 445-455(11)
Authors: Mahadevan, Daruka; Shirahatti, Nikhil


P-Glycoprotein - Implications of Metabolism of Neoplastic Cells and Cancer Therapy
pp. 457-468(12)
Authors: Breier, Albert; Barancik, Miroslav; Sulova, Zdenka; Uhrik, Branislav


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more